Therefore, these results suggest that the potential role of SIRT6 in the protection against oxidative stress damage could be a therapeutic target to treat the damage caused by the association between obesity and oxidative stress. The gene discussed is SIRT6; the disease is obesity due to melanocortin 4 receptor deficiency.